A significant peptide update in 2026 has set in motion a significant regulatory shift for some of the most widely researched compounds in the peptide space. Following an announcement by Robert F. Kennedy Jr., United States Secretary of Health and Human Services, 12 peptides previously classified under FDA Category 2 will be removed from that
There is no shortage of information about starting a peptide cycle. Protocols, dosing schedules, and expected benefits are well documented. What receives far less attention is the other end of the process. Stopping Peptide Therapy is a biological event in its own right, and for a meaningful proportion of people, the transition off a cycle
Table of Contents What Is Peptide Stacking? The Foundation of a Well-Designed Stack Five Principles Every Researcher Should Know Stacking Combinations With Research Backing Timing, Cycling and Receptor Health Mistakes That Compromise Your Protocol Why Compound Purity Cannot Be an Afterthought FAQs Understanding individual peptides is the first step. Knowing how to combine them is
Neural tissue damage presents substantial challenges within regenerative medicine, whether arising from acute trauma, chronic compression, or progressive degeneration. The nervous system’s limited inherent capacity for self-repair often results in lasting functional impairments that resist conventional therapeutic approaches. Emerging research on BPC-157, a synthetically stable pentadecapeptide derived from gastric protective proteins, has illuminated compelling pathways
